Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Mammography Quality Standards Act Requirements
Federal RegisterFeb 15, 2007
Ask Donna
What actually matters in this document.
Text
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N-0381]
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Mammography Quality Standards Act Requirements
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
DATES:
Fax written comments on the collection of information by March 19, 2007.
ADDRESSES:
To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-6974.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of the Chief Information Officer (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1472.
SUPPLEMENTARY INFORMATION:
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
The Mammography Quality Standards Act Requirements—21 CFR Part 900 (OMB Control Number 0910-0309)—Extension
Mammography Quality Standards Act requires the establishment of a Federal certification and inspection program for mammography facilities; regulations and standards for accreditation and certification bodies for mammography facilities, and standards for mammography equipment, personnel, and practices, including quality assurance. The intent of these regulations is to ensure safe, reliable, and accurate mammography on a nationwide level.
Under the regulations, as a first step in becoming certified, mammography facilities must become accredited by an FDA approved accreditation body. This requires undergoing a review of their clinical images and providing the accreditation body with information showing that they meet the equipment, personnel, quality assurance and quality control standards, and have a medical reporting and recordkeeping program, a medical outcomes audit program, and a consumer compliant mechanism. On the basis of this accreditation, facilities are then certified by FDA or an FDA-
approved State certification agency and must prominently display their certificate. These actions are taken to ensure safe, accurate, and reliable mammography on a nationwide basis.
In the
Federal Register
of September 22, 2006 (71 FR 55488), FDA published a 60-day notice soliciting public comments on the information collection requirements of the proposed collection. In response to that notice, no comments were received.
FDA estimates the burden of this collection of information as follows:
Table 1.—Estimated Annual Reporting Burden
21 CFR Section/ FDA Form
No. of Respondents
Annual Frequency per Response
Total Annual Responses
Hours per Response
Total Hours
Total Capital Costs
Total Operating & Maintenance Costs
900.3(b)(1)
0.33
1
0.33
1
0.33
900.3(b)(3) full
1
0.33
1
0.33
320
106
$10,000
900.3(b)(3) limited
2
5
1
5
30
150
900.3(d)(2)
0.1
1
0.1
30
3
900.3(d)(5)
0.1
1
0.1
30
3
900.3(e)
0.1
1
0.1
1
0.1
900.3(f)(2)
0.1
1
0.1
200
20
$36
900.4(c) facility
3
2,947
1
2,947
1.54
4,538
900.4(c) AB
4
6
1
6
378
2,268
$117,867
900.4(d) facility
3
2,947
1
2,947
0.77
2,269
900.4(d) AB
4
6
1
6
189
1,134
900.4(e) facility
3
8,840
1
8,840
1
8,840
$8,840
900.4(e) AB
4
6
1
6
1,473
8,838
900.4(f)
336
1
336
7
2,352
$77,840
900.4(h) facility
3
8,840
1
8,840
1
8,840
$3,536
900.4(h) AB
4
6
1
6
10
60
900.4(i)(2)
1
1
1
16
16
900.6(c)(1)
0.1
1
0.1
60
6
900.11(b)(3)
5
1
5
0.5
2.5
900.11(c)
270
1
270
5
1,350
900.12(c)(2)
8,840
4,072
36,000,000
0.083
3,000,000
$14,400,000
5
900.12(c)(2) patient refusal
5
89
1
89
0.5
44.5
900.12(h)(4)
5
1
5
1
5
900.12(j)(1) facility
3
25
1
25
200
5,000
$250
900.12(j)(1) AB
4
25
1
25
1,000
25,000
$750
900.12(j)(2)
3
1
3
100
300
$3,604
900.15(c)
5
1
5
2
10
900.15(d)(3)(ii)
1
1
1
2
2
900.18(c)
2
1
2
2
4
900.18(e)
2
1
2
1
2
900.21(b)
1
1
1
320
320
$30,000
$71
900.21(c)(2)
0.3
1
0.33
30
10
900.22(h)
6
200
1,200
0.083
100
900.22(i)
2
1
2
30
60
900.23
6
1
6
20
120
900.24(a)
0.3
1
0.3
200
60
$26
900.24(a)(2)
0.15
1
0.15
100
15
$13
900.24(b)
1.2
1
1.2
30
36
900.24(b)(1)
0.3
1
0.3
200
60
$26
900.24(b)(3)
0.15
1
0.15
100
15
$13
900.25(a)
0.2
1
0.2
16
3.2
FDA Form 3422
700
1
700
0.25
175
TOTAL
3,072,138
$40,000
$14,612,872
1
Refers to entities that are applying for the first time.
2
Refers to accreditation bodies applying to accredit specific Full Field Digital Mammography units.
3
Refers to the facility component of the burden for this requirement.
4
Refers to the accreditation body component of the burden for this requirement.
5
Refers to the situation where a patient specifically does not want to receive the lay summary of her exam.
Table 2. —Estimated Annual Recordkeeping Burden
21 CFR Section
Number of Recordkeepers
Annual Frequency of Recordkeeping
Total Annual Records
Hours per Record
Total Hours
Total Capital Costs
Total Operating & Maintenance Costs
900.4(g)
6
1
6
1
6
900.12(a)(1)(i)(B)(2)
89
1
89
8
712
900.12(a)(4)
8,840
4
35,360
1
35,360
900.12(c)(4)
8,840
1
8,840
1
8,840
$25,000
900.12(e)(13)
8,840
52
459,680
0.083
38,154
900.12(f)
8,840
1
8,840
16
141,440
900.12(h)(2)
8,840
2
17,680
1
17,680
900.22(a)
6
1
6
1
6
900.22(d)
6
1
6
1
6
900.22(e)
6
1
6
1
6
900.22(f)
3
1
3
1
3
900.22(g)
6
1
6
1
6
$60
900.25(b)
6
1
6
1
6
Total
242,225
$25,000
$60
This request for OMB approval now serves to consolidate previously issued information collection, OMB control number 0910-0580 into 0910-0309. The hourly burden as well as the associated operating costs were increased to better represent the actual burden and costs on facilities and accreditation bodies.
The following regulations were not included in the above burden tables because they were considered usual and customary practice and were part of the standard of care prior to the implementation of the regulations. Therefore, they resulted in no additional reporting or recordkeeping burden: 21 CFR 900.12(c)(1) and (c)(3) and § 900.3(f)(1) (21 CFR 900.3(f)(1)).
The following regulations were not included in the above burden tables because they were not considered applicable during the information collection period or their burdens were reported under other regulatory requirements. Therefore, they resulted in no additional reporting or recordkeeping burden: § 900.3(c), 21 CFR 900.11(b)(1) and (b)(2), and 900.24(c).
Dated: February 8, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7-2578 Filed 2-14-07; 8:45 am]
BILLING CODE 4160-01-S
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.